Management of otitis media-related diseases in children with a cochlear implant

Yung-Song Lin1

  • 1Department of Otolaryngology, Chi Mei Medical Center, Taipei Medical University, 190 Chung Hwa Road, Yung KanCity, Tainan County, Taiwan 700, ROC. kingear.lin@msa.hinet.net

Acta Oto-Laryngologica
|January 10, 2009
PubMed

Insights

Four of 19 children with cochlear implants (CI) developed cholesteatoma due to otitis media. Regular follow-up and prompt antibiotic treatment are crucial for children with CIs to prevent serious ear infections.

Area of Science:

  • Pediatric Otolaryngology
  • Medical Device Complications
  • Infectious Diseases

Background:

  • Otitis media is a common childhood illness.
  • Cochlear implants (CIs) are devices used to treat severe hearing loss.
  • The relationship between CIs and otitis media complications requires further investigation.

Purpose of the Study:

  • To evaluate treatment strategies and outcomes for otitis media-related conditions in pediatric patients with cochlear implants.

Main Methods:

  • A retrospective case review was conducted at a tertiary referral center.
  • The study included pediatric patients with a history of otitis media or related diseases in the implanted ear.
  • Treatment modalities encompassed antibiotics, tympanotomy, and tympanomastoidectomy.

Main Results:

  • Out of 186 children with CIs, 19 had otitis media; 4 of these developed cholesteatoma.
  • Other diagnoses included acute otitis media (10 children), middle ear effusion (4 children), and mastoiditis (1 child).
  • Surgery was necessary for cholesteatoma and mastoiditis cases, with 3 CIs explanted to remove cholesteatoma.

Conclusions:

  • Cochlear implant insertion may predispose to mastoid pneumatization issues, mucosal irritation, or infection.
  • Regular monitoring is essential for children with CIs, especially during common otitis media ages.
  • Prompt antibiotic treatment for suspected acute otitis media is recommended to prevent progression to chronic infection, cholesteatoma, or meningitis.
Abstract

Related Concept Videos

Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
287
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
223
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
257
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
387
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
447
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K